NCT00480506View on ClinicalTrials.gov

Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Thalassemia Major
Trial Locations (2)

02115

Dana-Farber Cancer Institute, Boston

Unknown

Tehran University of Medical Sciences, Tehran

All Listed Sponsors
collaborator

Tehran University of Medical Sciences

OTHER

lead

Dana-Farber Cancer Institute

OTHER

NCT00480506 - Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major | Biotech Hunter | Biotech Hunter